Latest News and Press Releases

Autolus Therapeutics to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress

Autolus Therapeutics announces appointment of Matthias Will, M.D. as Chief Development Officer

Autolus presents clinical data update at the Society of Hematologic Oncology (SOHO) Annual Meeting 2024

Autolus Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

Autolus Therapeutics to Present Three Clinical Data Updates on obe-cel at EHA

Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics to present three clinical data updates at the 2024 EHA Congress